搜索临床试验以:IBI939 Sintilimab
总计461个结果
-
Shanghai Zhongshan HospitalInnovent Biologics (Suzhou) Co. Ltd.招聘中
-
Peking Union Medical College HospitalHenan Cancer Hospital; Qilu Hospital of Shandong University; Beijing Tongren Hospital; Beijing Hospital 和其他合作者招聘中
-
Shanghai Changzheng Hospital完全的
-
Tianjin Medical University Cancer Institute and...招聘中
-
Sun Yat-sen University完全的放疗 | 信蒂利单抗 | 安罗替尼 | 自然杀伤/T 细胞淋巴瘤,鼻腔和鼻腔型 | 早期 | 聚乙二醇门冬酶 | 第二阶段 | 打开中国
-
Innovent Biologics (Suzhou) Co. Ltd.完全的
-
First Hospital of Shijiazhuang City未知
-
Fujian Medical University Union Hospital尚未招聘
-
Sichuan Cancer Hospital and Research InstituteInnovent Biologics, Inc.未知肿瘤 | 呼吸道疾病 | 肺部疾病 | 胸部肿瘤 | 非小细胞肺癌
-
Sichuan Cancer Hospital and Research InstituteFirst Affiliated Hospital Xi'an Jiaotong University; General Hospital of Ningxia Medical University 和其他合作者未知
-
Shandong Cancer Hospital and Institute招聘中
-
The First Affiliated Hospital of Zhengzhou University尚未招聘
-
Northwestern UniversityEisai Inc.未知男性乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | 三阴性乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阴性乳腺癌 | 孕激素受体阴性乳腺癌 | HER2 阴性乳腺癌美国
-
Peking Union Medical College HospitalChia Tai Tianqing Pharmaceutical Group Co., Ltd.; Xinda Biopharmaceutical Group尚未招聘
-
National Cancer Institute (NCI)完全的
-
Helsinn Healthcare SA完全的
-
China Medical University, ChinaShengjing Hospital; The People's Hospital of Liaoning Province; The First People's Hospital of... 和其他合作者未知
-
The First Affiliated Hospital of Soochow UniversityInnovent Biologics (Suzhou) Co. Ltd.招聘中